A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)
Journal article published in 2016 by
Antonio Avallone 
,
Maria Carmela Piccirillo,
Luigi Aloj,
Guglielmo Nasti,
Paolo Delrio,
Francesco Izzo,
Elena Di Gennaro,
Fabiana Tatangelo,
Vincenza Granata,
Ernesta Cavalcanti,
Piera Maiolino,
Francesco Bianco,
Pasquale Aprea,
Mario De Bellis,
Biagio Pecori
and other authors.
,
Maria Carmela Piccirillo,
Luigi Aloj,
Guglielmo Nasti,
Paolo Delrio,
Francesco Izzo,
Elena Di Gennaro,
Fabiana Tatangelo,
Vincenza Granata,
Ernesta Cavalcanti,
Piera Maiolino,
Francesco Bianco,
Pasquale Aprea,
Mario De Bellis,
Biagio Pecori
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 